Browse > Article
http://dx.doi.org/10.7314/APJCP.2014.15.18.7951

Cervical Pathology in Cytology-Negative/HPV-Positive Women: Results from Lampang Cancer Hospital, Thailand  

Paengchit, Kannika (Lampang Cancer Hospital, Faculty of Medicine, Khon Kaen University)
Kietpeerakool, Chumnan (Department of Obstetrics and Gynaecology, Faculty of Medicine, Khon Kaen University)
Wangchai, Warunee (Lampang Cancer Hospital, Faculty of Medicine, Khon Kaen University)
Pouraeng, Saifon (Lampang Cancer Hospital, Faculty of Medicine, Khon Kaen University)
Lalitwongsa, Somkiet (Lampang Cancer Hospital, Faculty of Medicine, Khon Kaen University)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.15, no.18, 2014 , pp. 7951-7954 More about this Journal
Abstract
Background: To evaluate the cervical pathology of cytology-negative/high-risk human papillomavirus (HR-HPV) positive-women. Materials and Methods: This study recruited 4,583 women aged 30-70 years who had undergone cervical screening by liquid-based cytology and HR-HPV test (14 HR-HPV types) at Lampang Cancer Hospital during October 2012 to July 2013. Colposcopy was carried out in all women. Results: One hundred and ninety-two (4.19%) women were found to be cytology-negative/HR-HPV-positive. However, 23 cases were excluded because of incomplete information, leaving 169 women for further analyses. Of these 169, 45 (26.6%) were infected with HPV 16/18 and 49 (29.0%) with multiple genotypes of HR-HPV. Nineteen of 169 (11.24%) women were found to have CIN 2-3. No women in the present study had AIS or invasive cervical lesions. Prevalence of CIN 2-3 among women infected with HPV 16/18 was 15.6% which was higher than the 9.68% in those with non-HPV 16/18 oncogenic types. Conclusions: Overall, 11% of cytology-negative/HR-HPV-positive women had significant cervical lesions. Risk of harboring such lesions was substantially increased among those who were HPV 16/18 positive.
Keywords
Cervical pathology; human papillomavirus; genotyping; HPV subtypes; CIN;
Citations & Related Records
Times Cited By KSCI : 2  (Citation Analysis)
연도 인용수 순위
1 Khan MJ, Castle PE, Lorincz AT, et al (2005). The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice. J Natl Cancer Inst, 97, 1072-9.   DOI   ScienceOn
2 Kietpeerakool C, Manopunya M, Phuprasertsak P, et al (2011). An audit of colposcopy appointment processes in women with abnormal cervical cytology. Cytopathology, 22, 184-8.
3 Kim K, Kim JJ, Kim SM, et al (2012). Prevalence and determinants of high-risk human papillomavirus infection in women with high socioeconomic status in Seoul, Republic of Korea. Asian Pac J Cancer Prev, 13, 269-73.   과학기술학회마을   DOI   ScienceOn
4 Kitchener HC, Almonte M, Thomson C, et al (2009). HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): a randomised controlled trial. Lancet Oncol, 10, 672-82.   DOI   ScienceOn
5 Rattanalappaiboon D, Kietpeerakool C, Kleebkaow P, et al (2014). Factors affecting compliance in the first year of postcolposcopy surveillance among women with a high incidence of cervical cancer. Int J Gynaecol Obstet, 124, 160-3.   DOI   ScienceOn
6 Leinonen M, Nieminen P, Kotaniemi-Talonen L, et al (2009). Age-specific evaluation of primary human papillomavirus screening vs conventional cytology in a randomized setting. J Natl Cancer Inst, 101, 1612-23.   DOI   ScienceOn
7 Moore MA, Attasara P, Khuhaprema T, et al (2010). Cancer epidemiology in mainland South-East Asia-past, present and future. Asian Pac J Cancer Prev, 11, 67-80.
8 Rijkaart DC, Berkhof J, Rozendaal L, et al (2012). Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial. Lancet Oncol, 13, 78-88.   DOI   ScienceOn
9 Ronco G, Giorgi-Rossi P, Carozzi F, et al (2010). Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial. Lancet Oncol, 11, 249-57.   DOI   ScienceOn
10 Siriaree S, Srisomboon J, Kietpeerakool C, et al (2006). Highgrade squamous intraepithelial lesion with endocervical cone margin involvement after cervical loop electrosurgical excision: what should a clinician do? Asian Pac J Cancer Prev, 7, 463-6.
11 Sui S, Jiao Z, Niyazi M, et al (2013). Genotype distribution and behavioral risk factor analysis of human papillomavirus infection in Uyghur women. Asian Pac J Cancer Prev, 14, 5861-5.   과학기술학회마을   DOI   ScienceOn
12 Swangvaree SS, Kongkaew P, Rugsuj P, et al (2010). Prevalence of high-risk human papillomavirus infection and cytologic results in Thailand. Asian Pac J Cancer Prev, 11, 1465-8.
13 Wright TC Jr, Stoler MH, Sharma A, et al (2011). Evaluation of HPV-16 and HPV-18 genotyping for the triage of women with high-risk HPV+cytology-negative results. Am J Clin Pathol, 136, 578-86.   DOI   ScienceOn
14 Massad LS, Einstein MH, Huh WK, et al (2013). 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. Obstet Gynecol, 121, 829-46.   DOI   ScienceOn
15 Cox JT, Castle PE, Behrens CM, et al (2013). Comparison of cervical cancer screening strategies incorporating different combinations of cytology, HPV testing, and genotyping for HPV 16/18: results from the ATHENA HPV study. Am J Obstet Gynecol, 208, 181-4.   DOI   ScienceOn
16 ASCUS-LSIL Traige Study (ALTS) Group (2003). A randomized trial on the management of low-grade squamous intraepithelial lesion cytology interpretations. Am J Obstet Gynecol, 188, 1393-400.   DOI
17 Chansaenroj J, Lurchachaiwong W, Termrungruanglert W, et al (2010). Prevalence and genotypes of human papillomavirus among Thai women. Asian Pac J Cancer Prev, 11, 117-22.